相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。eGFR Testing around the World Justice, Access, and Accuracy
Vivekanand Jha et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak et al.
KIDNEY INTERNATIONAL (2021)
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Suetonia C. Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review
Ikechi G. Okpechi et al.
BMJ OPEN (2021)
Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries
Marcello Tonelli et al.
JAMA NETWORK OPEN (2021)
Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems
Ikechi G. Okpechi et al.
NEPHROLOGY (2021)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
David C Wheeler et al.
Lancet Diabetes & Endocrinology (2020)
Updated methodological guidance for the conduct of scoping reviews
Micah D. J. Peters et al.
JBI EVIDENCE SYNTHESIS (2020)
Chronic Kidney Disease of Unknown Cause in Agricultural Communities
Richard J. Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Development and Validation of a Pragmatic Electronic Phenotype for CKD
Jenna M. Norton et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey
Aminu K. Bello et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Consolidated principles for screening based on a systematic review and consensus process
Mark J. Dobrow et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis
Kanran Wang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project
Htay Htay et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Yan Xie et al.
KIDNEY INTERNATIONAL (2018)
Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease
Linda L. Wong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Chronic kidney disease in low-income to middle-income countries: the case for increased screening
Cindy George et al.
BMJ GLOBAL HEALTH (2017)
The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program
Paul Komenda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
The Paucity of Evidence Supporting Screening for Stages 1-3 CKD in Asymptomatic Patients with or without Risk Factors
Amir Qaseem et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Routine Screening for CKD Should Be Done in Asymptomatic Adults ... Selectively
Jeffrey S. Berns
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Management of chronic kidney disease and its risk factors in eastern Nepal
Sanjib Kumar Sharma et al.
LANCET GLOBAL HEALTH (2014)
Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2013)
Reimbursement of Dialysis: A Comparison of Seven Countries
Raymond Vanholder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Screening for CKD and Cardiovascular Disease Risk Factors Using Mobile Clinics in Jalisco, Mexico
Jose Alfonso Gutierrez-Padilla et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Scoping studies: advancing the methodology
Danielle Levac et al.
IMPLEMENTATION SCIENCE (2010)
The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period
Susumu Takahashi et al.
KIDNEY INTERNATIONAL (2010)
Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
Kirsten Howard et al.
VALUE IN HEALTH (2010)
Population based screening for chronic kidney disease: cost effectiveness study
Braden Manns et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
How should proteinuria be detected and measured?
Edmund J. Lamb et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Principles of screening for chronic kidney disease
Bernard G. Jaar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Screening for chronic kidney disease: Where does Europe go?
Paul E. de Jong et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Screening for Proteinuria and Chronic Kidney Disease Risk Factors in Kinshasa: A World Kidney Day 2007 Study
Ernest K. Sumaili et al.
NEPHRON CLINICAL PRACTICE (2008)
Maximising benefit and minimising harm of screening
J. A. Muir Gray et al.
BRITISH MEDICAL JOURNAL (2008)
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease
David M. Kent et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey
Stein I. Hallan et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Experience with a program for prevention of chronic renal failure in India
MK Mani
KIDNEY INTERNATIONAL (2005)
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population
RT Gansevoort et al.
KIDNEY INTERNATIONAL (2005)
Screening for proteinuria in US adults - A cost-effectiveness analysis
LE Boulware et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data
TH Jafar et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
